# PacBio to Participate in the Jefferies Global Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/PACB/pacbio-to-participate-in-the-jefferies-global-healthcare-conference-c27c5d94
Ticker: PACB
Company: Pacific Biosciences
Source: Pacific Biosciences
Published: 2026-05-21 20:05 EST
## Summary

PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions,...

## Article Body
PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Jefferies’ Global Healthcare Conference on Thursday, June 4, 2026, at 2:00 PM ET in New York, New York.

A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com . A replay of the webcast will be available for at least 30 days following the event.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors: ir@pacb.com

Media: pr@pacb.com
## Recent Company News
- 2026-07-15 20:05 EST — [PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026](https://biopharmsignal.com/news/PACB/pacbio-to-report-second-quarter-2026-financial-results-on-august-5-2026-ad299ae5) — Source: Pacific Biosciences
- 2026-05-26 13:05 EST — [PacBio SPRQ-Nx Chemistry Now Shipping Worldwide, Enabling Sub-$300 HiFi Genomes for Large Scale Projects and AI-Enhanced Sequencing](https://biopharmsignal.com/news/PACB/pacbio-sprq-nx-chemistry-now-shipping-worldwide-enabling-sub-300-hifi-genomes-fo-ef99fc7e) — Source: Pacific Biosciences
- 2026-05-21 20:05 EST — [PacBio to Participate in the Jefferies Global Healthcare Conference](https://biopharmsignal.com/news/PACB/pacbio-to-participate-in-the-jefferies-global-healthcare-conference-c27c5d94) — Source: Pacific Biosciences
- 2026-05-11 13:05 EST — [HiFi Solves Sub-fertility Consortium in Asia Pacific Reports First Major Study Using HiFi Long-Read Sequencing to Investigate Unexplained Subfertility and Recurrent Pregnancy Loss](https://biopharmsignal.com/news/PACB/hifi-solves-sub-fertility-consortium-in-asia-pacific-reports-first-major-study-u-7eafc311) — Source: Pacific Biosciences
- 2026-05-07 20:05 EST — [PacBio Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/PACB/pacbio-announces-first-quarter-2026-financial-results-bc752f40) — Source: Pacific Biosciences
## Related News
- 2026-07-28 20:15 EST — BDX — [BD Board Declares Dividend](https://biopharmsignal.com/news/BDX/bd-board-declares-dividend-ea66eb4a)
- 2026-07-28 13:00 EST — ENLV — [Enlivex Announces $400,000,000 Private Placement](https://biopharmsignal.com/news/ENLV/enlivex-announces-400-000-000-private-placement-20e71a7a)
- 2026-07-28 12:30 EST — XRAY — [Dentsply Sirona Advances Commercial Growth Strategy in Canada Through Expanded Medline Sinclair Relationship](https://biopharmsignal.com/news/XRAY/dentsply-sirona-advances-commercial-growth-strategy-in-canada-through-expanded-m-e2440bb2)
- 2026-07-28 12:30 EST — RLMD — [Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer](https://biopharmsignal.com/news/RLMD/relmada-therapeutics-appoints-uro-oncology-leader-bipin-dalmia-as-chief-business-5c4d7b11)
- 2026-07-28 12:05 EST — RIGL — [Rigel Announces Conference Call and Webcast to Report Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/RIGL/rigel-announces-conference-call-and-webcast-to-report-second-quarter-2026-financ-5b987d7a)